142 related articles for article (PubMed ID: 12176473)
1. Therapeutic drug monitoring of tacrolimus early after liver transplantation.
Braun F; Peters B; Schütz E; Lorf T; Undre N; Oellerich M; Ringe B
Transplant Proc; 2002 Aug; 34(5):1538-9. PubMed ID: 12176473
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Oellerich M; Armstrong VW; Schütz E; Shaw LM
Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
[No Abstract] [Full Text] [Related]
3. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
4. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
[No Abstract] [Full Text] [Related]
5. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
6. Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept.
Ringe B; Braun F; Lorf T; Canelo R; Schütz E; Sattler B; Ramadori G
Transplant Proc; 1998 Jun; 30(4):1415-6. PubMed ID: 9636573
[No Abstract] [Full Text] [Related]
7. Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus.
Cantarovich M; Fridell J; Barkun J; Metrakos P; Besner JG; Deschênes M; Alpert E; Aalamian Z; Tchervenkov JI
Transplant Proc; 1998 Jun; 30(4):1460-1. PubMed ID: 9636592
[No Abstract] [Full Text] [Related]
8. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
Langers P; Press RR; den Hartigh J; Cremers SC; Baranski AG; Lamers CB; Hommes DW; van Hoek B
Ther Drug Monit; 2008 Aug; 30(4):456-61. PubMed ID: 18641539
[TBL] [Abstract][Full Text] [Related]
9. Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation.
Böttiger Y; Undre NA; Säwe J; Stevenson PJ; Ericzon BG
Transplant Proc; 2002 Aug; 34(5):1544-5. PubMed ID: 12176476
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics of FK 506 in living-related liver transplantation.
Satomura K; Ozaki N; Okajima H; Egawa H; Uemoto S; Inomata Y; Tanaka K; Yamaoka Y; Hashida T; Yasuhara M; Inui K
Transplant Proc; 1996 Apr; 28(2):1005. PubMed ID: 8623209
[No Abstract] [Full Text] [Related]
11. Follow the Area Under the Curve Not the Trough Concentration: A Case Study of Tacrolimus Monitoring in a Kidney Transplant Recipient Cotreated With Phenobarbital.
Izarn O; Morin MP; Ntobe-Bunkete B; Golbin L; Ferrand-Sorre MJ; Tron C; Lemaitre F
Ther Drug Monit; 2024 Jun; 46(3):285-287. PubMed ID: 38648637
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
[No Abstract] [Full Text] [Related]
13. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
[No Abstract] [Full Text] [Related]
14. Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient.
Ma TK; Chow KM; Kwan BC; Leung CB; Szeto CC; Li PK
Nephrology (Carlton); 2017 Feb; 22(2):184. PubMed ID: 28064453
[No Abstract] [Full Text] [Related]
15. Treatment of acute tacrolimus whole-blood elevation with phenobarbital in the pediatric liver transplant recipient.
Quirós-Tejeira RE; Chang IF; Bristow LJ; Karpen SJ; Goss JA
Pediatr Transplant; 2005 Dec; 9(6):792-6. PubMed ID: 16269053
[TBL] [Abstract][Full Text] [Related]
16. Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs.
Soldin SJ
Clin Biochem; 1998 Jul; 31(5):381-4. PubMed ID: 9721438
[No Abstract] [Full Text] [Related]
17. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants.
Almeida-Paulo GN; Lubomirov R; Alonso-Sanchez NL; Espinosa-Román L; Fernández Camblor C; Díaz C; Muñoz Bartola G; Carcas-Sansuán AJ
Transpl Int; 2014 Sep; 27(9):939-48. PubMed ID: 24861353
[
